PSYENCE BIOMEDICAL LTD. — Investor Relations & Filings
Psyence Biomedical Ltd. is a life science biotechnology company developing psychedelic and nature-centered solutions for mental health. The company specializes in creating therapies from naturally derived, non-synthetic psychedelic compounds, primarily psilocybin and ibogaine. Its core therapeutic focus is on palliative care, developing treatments for anxiety and depression in patients with life-threatening illnesses, including Adjustment Disorder in oncology patients. Additionally, Psyence Biomedical investigates the use of its botanical psilocybin for treating Alcohol Use Disorder (AUD) and other substance use disorders. The company employs a vertically integrated strategy, operating a federally licensed, ISO22000 certified facility for psilocybin cultivation and production to support its clinical trials and therapeutic development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer) | 2026-04-20 | English | |
| 6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer) | 2026-04-17 | English | |
| 6-K Filing | 2026-02-13 | English | |
| 6-K Filing | 2026-02-12 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-29 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-27 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 34691185 | 6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer) | 2026-04-20 | English | ||
| 34662593 | 6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer) | 2026-04-17 | English | ||
| 32277979 | 6-K Filing | 2026-02-13 | English | ||
| 32277962 | 6-K Filing | 2026-02-12 | English | ||
| 13664766 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-29 | English | ||
| 13664765 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-27 | English | ||
| 13664767 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-14 | English | ||
| 13664768 | Major Shareholding Notification 2026 | 2026-01-14 | English | ||
| 13664769 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-13 | English | ||
| 13664771 | CURRENT REPORT | 2026-01-13 | English | ||
| 13664770 | CURRENT REPORT | 2026-01-08 | English | ||
|
2025
4 filings
| |||||
| 13664773 | Major Shareholding Notification 2025 | 2025-12-11 | English | ||
| 13664772 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-21 | English | ||
| 13664775 | PROSPECTUS SUPPLEMENT | 2025-11-20 | English | ||
| 13664774 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ambrilia Biopharma Inc.
Biopharmaceutical company focused on novel treatments for o…
|
AMB | CA | Manufacturing |
|
AMGEN INC
A biotechnology company developing human therapeutics for s…
|
AMGN | US | Manufacturing |
|
Amicogen, Inc.
Industrial biotechnology company specializing in specialty …
|
092040 | KR | Manufacturing |
|
AMICUS THERAPEUTICS, INC.
Biotechnology company developing therapies for rare genetic…
|
FOLD | US | Manufacturing |
|
AMINOLOGICS CO.,LTD.
Specialty manufacturer of high-purity chiral amino acids an…
|
074430 | KR | Manufacturing |
|
Amneal Pharmaceuticals, Inc.
Develops, manufactures, and distributes generic and special…
|
AMRX | US | Manufacturing |
|
Amoy Diagnostics Co.,Ltd.
Develops molecular diagnostic kits and companion diagnostic…
|
300685 | CN | Manufacturing |
|
Amphastar Pharmaceuticals, Inc.
Develops, manufactures, and markets technically challenging…
|
AMPH | US | Manufacturing |
|
Amrutanjan Health Care Limited
Develops and distributes over-the-counter healthcare and pe…
|
AMRUTANJAN | IN | Manufacturing |
|
Amwill Health Care Limited
Develops, manufactures, and distributes a wide range of med…
|
544353 | IN | Manufacturing |
PSYENCE BIOMEDICAL LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35492/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35492 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35492 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35492 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35492}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PSYENCE BIOMEDICAL LTD. (id: 35492)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.